Skip to main content
. Author manuscript; available in PMC: 2015 Feb 10.
Published in final edited form as: Am J Nurs. 2013 Sep;113(9):28–38. doi: 10.1097/01.NAJ.0000434169.53750.14

Table 5.

Mean Comparisons of Loneliness and Quality of Life Scores Based on Medication Use

Variable n UCLA,
mean
SD t P QOL,
mean
SD t P
Lipid-lowering agent Yes 28 52.64 4.31 2.58 0.01a 24.80 4.64 0.69 0.49
No 29 49.62 4.45 25.68 5.04

Narcotic Yes 15 51.80 4.92 0.65 0.52 24.60 4.62 0.60 0.55
No 44 50.89 3.98 25.46 4.85

Benzodiazepine Yes 5 54.40 3.36 1.68 0.09 20.60 7.43 2.65 0.01 a
No 53 50.90 4.51 26.02 4.04

Diuretic Yes 9 52.67 3.77 0.97 0.33 22.22 6.20 2.20 0.03 b
No 50 51.06 4.65 25.93 4.34

Nitrate Yes 11 50.81 3.89 0.39 0.67 22.59 3.98 2.19 0.03 b
No 48 51.41 4.70 26.00 6.98

Anticoagulant Yes 13 54.07 3.22 2.89 < 0.01a 26.57 4.99 1.10 0.27
No 46 50.15 4.56 24.91 3.93

Calcium supplement Yes 7 47.71 3.40 2.14 0.04 b 26.14 1.58 0.48 0.63
No 53 51.60 4.63 25.21 0.67

Bronchodilator MDI Yes 7 53.86 3.62 1.66 0.1 20.28 7.01 3.19 < 0.01 a
No 53 50.79 4.68 25.99 4.03

MDI = multidose inhaler; QOL = quality of life; SD = standard deviation; t = t-test values; UCLA = University of California, Los Angeles Loneliness Scale (version 3).

a

Significant at the 0.01 level.

b

Significant at the 0.05 level.

Note: The number of participants does not sum to 60 in some cases because of missing data.